Skip Navigation



ToxSci Advance Access published online on May 28, 2008

Toxicological Sciences, doi:10.1093/toxsci/kfn107
This Article
Right arrow Advance Access manuscript (PDF) Freely available
Right arrow All Versions of this Article:
105/1/211    most recent
kfn107v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Bridges, C. C.
Right arrow Articles by Zalups, R. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bridges, C. C.
Right arrow Articles by Zalups, R. K.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2008. Published by Oxford University Press on behalf of the Society of Toxicology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

MRP2 and the DMPS- and DMSA-Mediated Elimination of Mercury in TR and Control Rats Exposed to Thiol S-conjugates of Inorganic Mercury

Christy C. Bridges, Lucy Joshee and Rudolfs K. Zalups

Mercer University School of Medicine, Division of Basic Medical Sciences, 1550 College Street, Macon, Georgia 31207

Corresponding Author: Christy C. Bridges, Ph.D., Mercer University School of Medicine, Division of Basic Medical Sciences, 1550 College Street, Macon, Georgia 31207. Phone: 478-301-2086. Fax: 478-301-5487. Email: bridges_cc{at}mercer.edu

Received April 21, 2008; revision received May 20, 2008; accepted May 21, 2008


   Abstract

Cysteine (Cys) and homocysteine (Hcy)-S-conjugates of inorganic mercury (Hg2+) are transportable species of Hg2+ that are taken up readily by proximal tubular cells. The metal chelators, 2, 3-dimercaptopropane-1-sulfonic acid (DMPS) and meso-2, 3-dimercaptosuccinic acid (DMSA), have been used successfully to extract Hg2+ from these cells, presumably via the multidrug resistance protein, Mrp2. In the current study, we tested the hypothesis that Mrp2 is involved in the DMPS- and DMSA-mediated extraction of Hg2+ following administration of Hg2+ as an S-conjugate of Cys or Hcy. To test this hypothesis, control and TR (Mrp2-deficient) rats were injected with 0.5 µmol/kg HgCl2 (containing 203Hg2+) conjugated to 1.25 µmol/kg Cys or Hcy. After 24h and 28h, rats were treated with saline or 100 mg/kg DMPS or DMSA. Tissues were harvested 48h after Hg2+ exposure. The renal and hepatic burden of Hg2+ was greater in saline-injected TR rats than in corresponding controls. Accordingly, the content of Hg2+ in the urine and feces was less in TR rats than in controls. Following treatment with DMPS or DMSA, the renal content of Hg2+ in both groups of rats was reduced significantly and the urinary excretion of Hg2+ was increased. In liver, the effect of each chelator appeared to be dependent upon the form in which Hg2+ was administered. In vitro experiments provide direct evidence indicating that DMPS and DMSA-S-conjugates of Hg2+ are substrates for Mrp2. Overall, these data support our hypothesis that Mrp2 is involved in the DMPS and DMSA-mediated extraction of the body burden of Hg2+.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.